Evaluating the FDA regenerative medicine framework: opportunities for stakeholders

被引:6
作者
Richardson, Elizabeth [1 ]
Akkas, Farzana [1 ]
Master, Zubin [2 ,3 ]
机构
[1] Pew Charitable Trusts, Hlth Care Prod Project, 901 E St NW, Washington, DC 20004 USA
[2] Mayo Clin, Biomed Eth Res Program, 200 First St SW, Rochester, MN 55905 USA
[3] Mayo Clin, Ctr Regenerat Med, 200 First St SW, Rochester, MN 55905 USA
关键词
drug regulation; FDA; laws; regenerative medicine; unproven stem cell interventions; TO-CONSUMER MARKETPLACE; STEM-CELL; US; INFORMATION;
D O I
10.2217/rme-2020-0073
中图分类号
Q813 [细胞工程];
学科分类号
摘要
引用
收藏
页码:1825 / 1832
页数:8
相关论文
共 52 条
  • [1] Alliance for Regenerative Medicine, 2019, Q3 2019 DAT REP
  • [2] [Anonymous], 2018, STEM CELL BAS CLIN T
  • [3] Bajek A, 2011, STEM CELL STUD, V1, P90
  • [4] Concise Review: A Comprehensive Analysis of Reported Adverse Events in Patients Receiving Unproven Stem Cell-Based Interventions
    Bauer, Gerhard
    Elsallab, Magdi
    Abou-El-Enein, Mohamed
    [J]. STEM CELLS TRANSLATIONAL MEDICINE, 2018, 7 (09) : 676 - 685
  • [5] Responsibilities of Health Care Professionals in Counseling and Educating PatientsWith Incurable Neurological Diseases Regarding "Stem Cell Tourism" Caveat Emptor
    Bowman, Michelle
    Racke, Michael
    Kissel, John
    Imitola, Jaime
    [J]. JAMA NEUROLOGY, 2015, 72 (11) : 1342 - 1345
  • [6] Emerson B, 2018, THE BISMARCK TRIBUNE
  • [7] Empire Medical Training, 2020, INT STEM CELL REG TH
  • [8] EuroStemCell, 2020, EDUCATION
  • [9] Federation of State Medical Boards, 2019, PHYS DAT CTR
  • [10] Characterizing Direct-to-Consumer Stem Cell Businesses in the Southwest United States
    Frow, Emma K.
    Brafman, David A.
    Muldoon, Anna
    Krum, Logan
    Williams, Paige
    Becker, Bryson
    Nelson, John P.
    Pritchett, Ashley
    [J]. STEM CELL REPORTS, 2019, 13 (02): : 247 - 253